James Sidoti
Stock Analyst at Sidoti & Co.
(2.87)
# 1,525
Out of 5,165 analysts
8
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $17.85 | +56.86% | 3 | Aug 5, 2025 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $150 | $2.29 | +6,450.22% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $112.23 | -69.71% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $14.51 | +320.40% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $17.85
Upside: +56.86%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $150
Current: $2.29
Upside: +6,450.22%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $112.23
Upside: -69.71%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $14.51
Upside: +320.40%